Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
December 3, 2014
Reduced estimated glomerular filtration rate affects outcomes 3 months after intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study
Tetsuya Miyagi, Masatoshi Koga, Hiroshi Yamagami, et al.
Stroke
|
October 1, 2011
Low-dose intravenous recombinant tissue-type plasminogen activator therapy for patients with stroke outside European indications: Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rtPA Registry
Masatoshi Koga, Yoshiaki Shiokawa, Jyoji Nakagawara, et al.
Stroke
|
September 18, 2012
Conjugate eye deviation in acute intracerebral hemorrhage: stroke acute management with urgent risk-factor assessment and improvement--ICH (SAMURAI-ICH) study
Shoichiro Sato, Masatoshi Koga, Hiroshi Yamagami, et al.
Journal of the Neurological Sciences
|
April 16, 2011
CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry
Masatoshi Koga, Kazumi Kimura, Kensaku Shibazaki, et al.
Journal of the Neurological Sciences
|
December 17, 2015
A multicenter, prospective, observational study of warfarin-associated intracerebral hemorrhage: The SAMURAI-WAICH study
Masato Osaki, Masatoshi Koga, Koichiro Maeda, et al.
Stroke
|
January 19, 2013
Impact of early blood pressure variability on stroke outcomes after thrombolysis: the SAMURAI rt-PA Registry
Kaoru Endo, Kazuomi Kario, Masatoshi Koga, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
October 16, 2012
Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry
Tetsuya Miyagi, Masatoshi Koga, Yoshiaki Shiokawa, et al.
Stroke
|
June 1, 2026
Impact of Cerebral Small Vessel Disease on Functional Decline: Bleeding With Antithrombotic Therapy 2 Study
Yoshito Arakaki, Kaori Miwa, Masatoshi Koga, et al.
Journal of Hypertension
|
September 20, 2012
Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage: a prospective, multicenter, observational study (the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study)
Masatoshi Koga, Kazunori Toyoda, Hiroshi Yamagami, et al.
Stroke
|
July 7, 2020
Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2
Mayumi Fukuda-Doi, Haruko Yamamoto, Masatoshi Koga, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
December 3, 2014
Reduced estimated glomerular filtration rate affects outcomes 3 months after intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study
Tetsuya Miyagi, Masatoshi Koga, Hiroshi Yamagami, et al.
Stroke
|
October 1, 2011
Low-dose intravenous recombinant tissue-type plasminogen activator therapy for patients with stroke outside European indications: Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rtPA Registry
Masatoshi Koga, Yoshiaki Shiokawa, Jyoji Nakagawara, et al.
Stroke
|
September 18, 2012
Conjugate eye deviation in acute intracerebral hemorrhage: stroke acute management with urgent risk-factor assessment and improvement--ICH (SAMURAI-ICH) study
Shoichiro Sato, Masatoshi Koga, Hiroshi Yamagami, et al.
Journal of the Neurological Sciences
|
April 16, 2011
CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry
Masatoshi Koga, Kazumi Kimura, Kensaku Shibazaki, et al.
Journal of the Neurological Sciences
|
December 17, 2015
A multicenter, prospective, observational study of warfarin-associated intracerebral hemorrhage: The SAMURAI-WAICH study
Masato Osaki, Masatoshi Koga, Koichiro Maeda, et al.
Stroke
|
January 19, 2013
Impact of early blood pressure variability on stroke outcomes after thrombolysis: the SAMURAI rt-PA Registry
Kaoru Endo, Kazuomi Kario, Masatoshi Koga, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
October 16, 2012
Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry
Tetsuya Miyagi, Masatoshi Koga, Yoshiaki Shiokawa, et al.
Stroke
|
June 1, 2026
Impact of Cerebral Small Vessel Disease on Functional Decline: Bleeding With Antithrombotic Therapy 2 Study
Yoshito Arakaki, Kaori Miwa, Masatoshi Koga, et al.
Journal of Hypertension
|
September 20, 2012
Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage: a prospective, multicenter, observational study (the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study)
Masatoshi Koga, Kazunori Toyoda, Hiroshi Yamagami, et al.
Stroke
|
July 7, 2020
Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2
Mayumi Fukuda-Doi, Haruko Yamamoto, Masatoshi Koga, et al.
Page
of 7